TRAPPC8 c.3217A>G ;(p.I1073V)

Variant ID: 18-29435742-T-C

NM_014939.3(TRAPPC8):c.3217A>G;(p.I1073V)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


bMSAF is a prognostic predictor for advanced hepatocellular carcinoma patients treated with immune checkpoint inhibitor camrelizumab and anti-angiogenic agent apatinib combination therapy.

Clinical And Translational Medicine
Xu, Gehan G; Cui, Liang L; Li, Jin J; Wang, Quanren Q; Li, Pansong P; Xia, Xuefeng X; Yi, Xin X; Guan, Quanlin Q; Xu, Jianming J
Publication Date: 2022-10

Variant appearance in text: TRAPPC8: 3217A>G; Ile1073Val
PubMed Link: 36245284
Variant Present in the following documents:
  • CTM2-12-e1086-s010.xlsx, sheet 5
  • CTM2-12-e1086-s010.xlsx, sheet 4
View BVdb publication page